![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 27, 24274-24279, July 5, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
From the Child Study Center, Yale University School of Medicine,
New Haven, Connecticut 06520
A family of protein tyrosine
phosphatases enriched within the central nervous system called striatal
enriched phosphatase (STEP) has been implicated in the regulation
of the N-methyl-D-aspartate receptor.
STEP61, a membrane-associated isoform located in the postsynaptic densities (PSDs) of striatal neurons, contains two transmembrane domains, two proline-rich domains, and a
kinase-interacting motif. This study demonstrates that
STEP61 associates with Fyn, a member of the Src family
kinases that is also enriched in PSDs. By using human embryonic kidney
293 cells for co-transfection, we determined that a substrate-trapping
variant (STEP61 CS) binds to Fyn but not to other members
of the Src family present in PSDs. In a complementary experiment,
myc-tagged Fyn immunoprecipitates STEP61 CS.
STEP61 binds to Fyn through one of its proline-rich domains
and the kinase-interacting motif domain, whereas Fyn binds to
STEP61 through its Src homology 2 domain and the unique
N-terminal domain. STEP61 CS pulls down Fyn when the
Tyr420 site is phosphorylated. In vitro,
wild-type STEP61 dephosphorylates Fyn at Tyr420
but not at Tyr531. These results suggest that STEP
regulates the activity of Fyn by specifically dephosphorylating the
regulatory Tyr420 and may be one mechanism by which Fyn
activity is decreased within PSDs.
We dedicate this work to the memory of Dr. Akira Okamura.
To whom correspondence should be addressed. Present address: 48480 Lakeview Blvd., Fremont, CA 94538. Tel.: 510-413-9216; Fax:
510-226-4901; E-mail: tnguyen@lumicyte.com.
This article has been cited by other articles:
![]() |
D. V. Venkitaramani, J. Chin, W. J. Netzer, G. K. Gouras, S. Lesne, R. Malinow, and P. J. Lombroso {beta}-Amyloid Modulation of Synaptic Transmission and Plasticity J. Neurosci., October 31, 2007; 27(44): 11832 - 11837. [Full Text] [PDF] |
||||
![]() |
M. Bjarnadottir, D. L. Misner, S. Haverfield-Gross, S. Bruun, V. G. Helgason, H. Stefansson, A. Sigmundsson, D. R. Firth, B. Nielsen, R. Stefansdottir, et al. Neuregulin1 (NRG1) Signaling through Fyn Modulates NMDA Receptor Phosphorylation: Differential Synaptic Function in NRG1+/- Knock-Outs Compared with Wild-Type Mice J. Neurosci., April 25, 2007; 27(17): 4519 - 4529. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Rahmani APRO4 negatively regulates Src tyrosine kinase activity in PC12 cells J. Cell Sci., February 15, 2006; 119(4): 646 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chin, J. J. Palop, J. Puolivali, C. Massaro, N. Bien-Ly, H. Gerstein, K. Scearce-Levie, E. Masliah, and L. Mucke Fyn Kinase Induces Synaptic and Cognitive Impairments in a Transgenic Mouse Model of Alzheimer's Disease J. Neurosci., October 19, 2005; 25(42): 9694 - 9703. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Mansuy STEPping into Position: A New Player in the NMDA Receptor Game Mol. Interv., September 1, 2002; 2(5): 282 - 284. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |